Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

With plans to add 40 to its workforce this year, digital pathology company Proscia raised a $37M Series C

Proscia
By Author Proscia | June 14, 2022

The Series C will allow Proscia to invest in product development, accelerate the adoption of computational pathology and grow its team. It will also scale its commercial operations, including sales, marketing and support teams, and will grow its distribution partnerships following a recent agreement with Siemens Healthineers.

Our website uses cookies. By using this site, you agree to its use of cookies.